Velan Capital Investment Management LP Last Quarter Change: USA Stocks, Unchanged

Velan Capital Investment Management LP quarter change: USA Stocks, Unchanged

In share positions in stocks (listed in the US), from the quarter ended 2026-03-31 to 2026-06-30, Velan Capital Investment Management LP opened 6 positions, added to 10, reduced 9, sold out of 4 and left 23 unchanged. The largest increase in value was MPLT (+$7,644,770); the largest decrease was ESPR (-$4,712,800).

MPLT: Country of operation United States; Class COM; Shares 2026-03-31 492,893; Shares 2026-06-30 492,893.
STRO: Country of operation United States; Class COM SHS; Shares 2026-03-31 512,160; Shares 2026-06-30 512,160.
HRTX: Country of operation United States; Class COM; Shares 2026-03-31 8,753,290; Shares 2026-06-30 8,753,290.
AVR: Country of operation United States; Class COM; Shares 2026-03-31 700,000; Shares 2026-06-30 700,000.

Two Form 13F-HR filings compared (SEC CIK 1848809): 2026-03-31 (filed 2026-05-15) and 2026-06-30 (filed 2026-08-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.

Stock	Country of operation	Class	Shares 2026-03-31	Shares 2026-06-30	Value 2026-03-31	Value 2026-06-30	Value change
MPLT MAPLIGHT THERAPEUTICS INC	United States	COM	492,893	492,893	$10,020,515	$17,665,285	+$7,644,770
STRO SUTRO BIOPHARMA INC	United States	COM SHS	512,160	512,160	$12,757,906	$17,003,712	+$4,245,806
HRTX HERON THERAPEUTICS INC	United States	COM	8,753,290	8,753,290	$7,003,507	$3,735,904	-$3,267,603
AVR ANTERIS TECHNOLOGIES GLOBAL	United States	COM	700,000	700,000	$3,885,000	$6,895,000	+$3,010,000
EDSA EDESA BIOTECH INC	Canada	COM NEW	827,500	827,500	$4,327,825	$6,727,575	+$2,399,750
RZLT REZOLUTE INC	United States	COM NEW	750,000	750,000	$2,287,500	$3,900,000	+$1,612,500
JSPR JASPER THERAPEUTICS INC	United States	COM NEW	2,668,395	2,668,395	$2,338,047	$1,123,394	-$1,214,653
NSRX NASUS PHARMA LTD	Israel	ORD SHS	359,390	359,390	$797,846	$1,257,865	+$460,019
VRCA VERRICA PHARMACEUTICALS INC	United States	COM SHS	471,559	471,559	$2,494,547	$2,885,941	+$391,394
EPRX EUPRAXIA PHARMACEUTICALS INC		COM	352,000	352,000	$2,548,480	$2,326,720	-$221,760
NRIX NURIX THERAPEUTICS INC	United States	COM	16,000	16,000	$248,000	$388,160	+$140,160
DTIL PRECISION BIOSCIENCES INC	United States	COM NEW	40,000	40,000	$220,000	$314,400	+$94,400
ARTV ARTIVA BIOTHERAPEUTICS INC	United States	COM	25,000	25,000	$161,000	$242,500	+$81,500
REPL REPLIMUNE GROUP INC	United States	COM	20,000	20,000	$153,000	$221,400	+$68,400
PTGX PROTAGONIST THERAPEUTICS INC	United States	COM	3,700	3,700	$389,980	$453,546	+$63,566
LRMR LARIMAR THERAPEUTICS INC	United States	COM	33,000	33,000	$148,500	$100,650	-$47,850
XLO XILIO THERAPEUTICS INC	United States	COM	14,285	14,285	$120,137	$136,850	+$16,713
SNDX SYNDAX PHARMACEUTICALS INC	United States	COM	10,000	10,000	$233,600	$218,600	-$15,000
GOSS GOSSAMER BIO INC	United States	COM	70,000	70,000	$22,995	$11,522	-$11,473
PRQR PROQR THRAPEUTICS N V		SHS EURO	45,000	45,000	$72,900	$83,700	+$10,800
IMNM IMMUNOME INC	United States	COM	10,000	10,000	$218,700	$211,900	-$6,800
MLYS MINERALYS THERAPEUTICS INC	United States	COM	11,000	11,000	$297,990	$296,780	-$1,210
CRBP CORBUS PHARMACEUTICALS HLDGS	United States	COM NEW	26,000	26,000	$244,140	$243,880	-$260

Similar Firms

Firm Name	Country	13F Value	Holdings
Braun-Bostich & Associates Inc.	United States	$0.160B	126
Erickson Financial Group, LLC	United States	$0.160B	25
Cornerstone Select Advisors, LLC	United States	$0.160B	124
Blackston Financial Advisory Group, LLC	United States	$0.160B	106
Fairbanks Capital Management, Inc.	United States	$0.160B	51
Sanchez Levi Garrett	United States	$0.159B	75
Palacios Wealth Management, LLC	United States	$0.160B	75
RICHARDSON FINANCIAL SERVICES INC.	United States	$0.160B	1,132
AFFINITY INVESTMENT ADVISORS, LLC	United States	$0.160B	137
Sterling Manor Financial, LLC	United States	$0.160B	39